Search Results - "Martín‐Varillas, José Luis"
-
1
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
Published in American journal of ophthalmology (01-04-2019)“…Cystoid macular edema (CME) is a leading cause of blindness. This study assessed the efficacy and safety of tocilizumab (TCZ) in refractory CME. Retrospective…”
Get full text
Journal Article -
2
Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients
Published in Journal of rheumatology (01-05-2021)“…In a large series of White patients with refractory uveitis due to Behçet disease (BD) being treated with infliximab (IFX), we assessed (1) long-term efficacy…”
Get full text
Journal Article -
3
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
Published in Therapeutic advances in musculoskeletal disease (2022)“…Blau syndrome (BS) is an autoinflammatory disorder characterized by non-caseating granulomatous dermatitis, arthritis, and uveitis. We present a case of…”
Get full text
Journal Article -
4
Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis
Published in The Journal of dermatological treatment (17-11-2017)“…Purpose: Psoriasis patients have high risk of atherosclerosis, characterized by endothelial dysfunction. We aimed to study the association of the endothelial…”
Get full text
Journal Article -
5
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study
Published in Rheumatology (Oxford, England) (01-05-2018)“…Abstract Objective To assess the efficacy of tocilizumab (TCZ) in refractory uveitis of Behçet's disease (BD). Methods Multicentre study of patients with…”
Get full text
Journal Article -
6
Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice
Published in Clinical and experimental rheumatology (01-09-2020)“…The objective of the present study was to assess the efficacy of apremilast (APR) in the management of refractory oral and/or genital ulcers in patients with…”
Get more information
Journal Article -
7
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Published in Clinical and experimental rheumatology (01-01-2022)“…Rapid control of intraocular inflammation in non-infectious uveitis (NIU) is mandatory to avoid irreversible structural and functional damage. In this study,…”
Get more information
Journal Article -
8
SER recommendations on treatment of refractory Behçet's syndrome
Published in Reumatología clinica (Barcelona) (01-04-2024)“…To develop multidisciplinary recommendations based on available evidence and expert consensus for the therapeutic management of patients with refractory…”
Get full text
Journal Article -
9
Biologic therapy in refractory Neurobehçet's disease: a multicenter study of 41 patients and literature review
Published in Rheumatology (Oxford, England) (15-02-2022)“…To assess efficacy and safety of biologic therapy (BT) in Neurobehçet's disease (NBD) refractory to glucocorticoids and at least one conventional…”
Get full text
Journal Article -
10
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review
Published in Clinical and experimental rheumatology (01-07-2018)“…To assess the efficacy of golimumab (GLM), a fully humanised anti-TNF-α monoclonal antibody, in refractory juvenile idiopathic arthritis (JIA)-associated…”
Get full text
Journal Article -
11
Biologic therapy in refractory neurobehçet’s disease: a multicentre study of 41 patients and literature review
Published in Rheumatology (Oxford, England) (02-11-2022)“…OBJECTIVESTo assess efficacy and safety of biologic therapy (BT) in neurobehçet's disease (NBD) refractory to glucocorticoids and at least one conventional…”
Get full text
Journal Article -
12
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice
Published in Journal of rheumatology (01-10-2021)“…Tofacitinib (TOF) is the first Janus kinase (JAK) inhibitor approved for psoriatic arthritis (PsA). It has shown efficacy in patients refractory to anti-tumor…”
Get full text
Journal Article -
13
Recomendaciones SER sobre el tratamiento del síndrome de Behçet refractario
Published in Reumatología clinica (01-04-2024)“…Elaborar recomendaciones multidisciplinares, basadas en la evidencia disponible y el consenso de expertos, para el manejo terapéutico de los pacientes con…”
Get full text
Journal Article -
14
Epidemiology of Neuro-Behçet's Disease in Northern Spain 1999-2019: A Population-Based Study
Published in Journal of clinical medicine (05-09-2024)“…: Neuro-Behçet's disease (NBD) is one of the most severe complications of Behçet's disease (BD). The incidence of NBD varies widely worldwide. This study aimed…”
Get full text
Journal Article -
15
-
16
E102 Apremilast in real practice experience and learnings from our 100 patients with psoriasis and psoriatic arthritis
Published in Rheumatology (Oxford, England) (01-04-2019)Get full text
Journal Article -
17
E039 Late onset cryopyrin-associated periodic syndrome due to myeloid-restricted somatic NLRP3 mosaicism and ankylosing spondylitis
Published in Rheumatology (Oxford, England) (01-04-2019)Get full text
Journal Article -
18
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
Published in Rheumatic & musculoskeletal diseases open (01-12-2022)“…ObjectivesTo evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to immune-mediated inflammatory diseases (IMID).MethodsMulticentre…”
Get full text
Journal Article